Predicting Response to Medical Treatment in Acromegaly via Granulation Pattern, Expression of Somatostatin Receptors Type 2 and 5 and E-Cadherin. [PDF]
Gliga MC, Chinezu L, Pascanu IM.
europepmc +1 more source
Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management. [PDF]
Grottoli S +6 more
europepmc +1 more source
The association between biochemical control and cardiovascular risk factors in acromegaly [PDF]
core +1 more source
Healthcare utilization and costs among patients with acromegaly in the United States. [PDF]
Quock TP +8 more
europepmc +1 more source
Personalized Medicine in Acromegaly: The ACROFAST Study.
Marques-Pamies M +36 more
europepmc +1 more source
Management of acromegaly beyond primary surgery: efficacy and safety of repeat surgery and radiotherapy. [PDF]
Atai S +4 more
europepmc +1 more source
Assessment of the therapeutic value of new medicines marketed in Australia [PDF]
core +1 more source
Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance. [PDF]
Popa Ilie IR +8 more
europepmc +1 more source

